Clinical Trial Update: Aspirin Dosing in Diabetic Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating aspirin dosing in patients with type 2 diabetes mellitus and coronary artery disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University of Florida | Conditions: Type 2 Diabetes Mellitus, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2012-03-06